Topic

Aetna (CVS Health)

A collection of 1075 issues

Myths vs. Facts: Getting Tecentriq (atezolizumab) Covered by Aetna (CVS Health) in Pennsylvania

Answer Box: Tecentriq (atezolizumab) requires prior authorization from Aetna (CVS Health) in Pennsylvania, with approval based on FDA-indicated use, PD-L1 testing results (≥1% for adjuvant NSCLC, ≥50% for first-line metastatic), and documentation of failed alternatives where required. If denied after internal appeal, Pennsylvania's Independent External Review program offers
5 min read

How to Get Trikafta (Elexacaftor/Tezacaftor/Ivacaftor) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Trikafta Covered by Aetna CVS Health in Illinois Aetna CVS Health requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) with specific genetic and clinical documentation. You'll need CFTR genotype confirmation, baseline liver tests, and CF specialist consultation. Submit through the Aetna provider portal or call
5 min read

How to Get Imbruvica (ibrutinib) Covered by Aetna CVS Health in Michigan: Complete Guide to Prior Authorization, Appeals, and Financial Support

Answer Box: Fastest Path to Approval Imbruvica (ibrutinib) requires prior authorization from Aetna CVS Health in Michigan, with no step therapy for CLL/SLL. Your oncologist submits PA documentation (diagnosis, prior treatments, medical necessity) via Aetna's provider portal. Standard decisions take 15 business days; expedited requests 72 hours.
5 min read

How to Get Qinlock (ripretinib) Covered by Aetna CVS Health in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Qinlock Covered by Aetna CVS Health in Florida Qinlock (ripretinib) requires prior authorization from Aetna CVS Health and is classified as non-formulary (Tier 5), requiring documented failure of three prior kinase inhibitors: imatinib, sunitinib, and regorafenib. Your oncologist submits the PA request through the Aetna provider portal
6 min read